Graves’ Disease
Terry J. Smith, László Dávid Hegedűs · New England Journal of Medicine · 2016
Graves' disease is an autoimmune disorder in which the thyroid is activated by antibodies to the thyrotropin receptor. The hyperthyroidism that develops is one of many somatic and psychiatric manifestations of the disease that can affect the quality and length of life.
Cited by 1,257 works. doi:10.1056/nejmra1510030
Authors
References
- Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
- ABERRANT EXPRESSION OF HLA-DR ANTIGEN ON THYROCYTES IN GRAVES' DISEASE: RELEVANCE FOR AUTOIMMUNITY
- Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists
- Graves' Ophthalmopathy
- Relation between Therapy for Hyperthyroidism and the Course of Graves' Ophthalmopathy
- Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis
- Iodine deficiency and thyroid disorders
- Consensus Statement of the European Group on Graves' Orbitopathy (EUGOGO) on Management of Graves' Orbitopathy
- Cancer Mortality Following Treatment for Adult Hyperthyroidism
- Clinical Features of Graves' Ophthalmopathy in an Incidence Cohort